Transaction · 0001606302-26-000007

McMinn Rachel

McMinn Rachel, CEO, reported a transaction classified as exercise at Neurogene Inc. involving 756.000000 shares for an estimated $19141.92. Reported holdings after the transaction were 1345063.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO
NGNENeurogene Inc.
Filing timeOct 02
Trade dateSep 22, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NGNE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NGNE since 2026-10-02Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001606302-26-000007
Common Stock
Transaction date
Sep 22, 2026
Filed Oct 02, 2026, 06:49 PM · 10d delay
Shares
756 sh
$25.32 per share
Estimated value
$19.1k
Computed from shares × price
Holdings after
1.34M sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 10 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Direct Ownership
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Includes (a) 15,933 restricted stock units that vest annually in equal installments on March 23, 2027 and March 23, 2028; and (b) 25,900 restricted stock units that vest annually in equal installments…

  2. F2

    This option is fully vested and exercisable.

Original filing · 0001606302-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NGNE